(Q33259057)

24 July 2017

title

Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques (English)

1 reference

24 July 2017

author

Andrew James McMichael

4

object named as

Andrew J McMichael

1 reference

24 July 2017

Eung-Jun Im

1

1 reference

24 July 2017

Joseph P Nkolola

2

1 reference

24 July 2017

Kati di Gleria

3

1 reference

24 July 2017

Tomás Hanke

5

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

European Journal of Immunology

24 July 2017

published in

1 reference

24 July 2017

volume

36

1 reference

24 July 2017

issue

10

1 reference

24 July 2017

page(s)

2574-2584

1 reference

Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

HIV vaccine design and the neutralizing antibody problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Non-human primate models for AIDS vaccine research

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Progress toward an HIV vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200636482

1 reference

7 January 2021

Evolutionary and immunological implications of contemporary HIV-1 variation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

The repertoire of T cells shaped by a single MHC/peptide ligand.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

T cell cross-reactivity and conformational changes during TCR engagement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

HIV T cell vaccines, the importance of clades

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636482

7 January 2021

Identifiers

DOI

10.1002/EJI.200636482

1 reference

24 July 2017

1 reference